Drugs / PF-07905428
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06671834 | Nov 2024 → Dec 2025 | acne | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07905428 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06671834 ↗ |
| Route | Topical | “Topical solution of PF-07905428 0.08% or PF-07905428 0.24%” NCT06671834 ↗ |